KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Vir Biotechnology (VIR) Income from Continuing Operations (2018 - 2025)

Vir Biotechnology's Income from Continuing Operations history spans 8 years, with the latest figure at 42923000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations rose 58.96% to 42923000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 437987000.0, a 16.09% increase, with the full-year FY2025 number at 437987000.0, up 16.09% from a year prior.
  • Income from Continuing Operations hit 42923000.0 in Q4 2025 for Vir Biotechnology, up from 163141000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for VIR hit a ceiling of 525254000.0 in Q4 2021 and a floor of 213717000.0 in Q3 2024.
  • Historically, Income from Continuing Operations has averaged 26532150.0 across 5 years, with a median of 107773500.0 in 2024.
  • Biggest five-year swings in Income from Continuing Operations: surged 597.17% in 2021 and later tumbled 223.75% in 2022.
  • Tracing VIR's Income from Continuing Operations over 5 years: stood at 525254000.0 in 2021, then plummeted by 119.34% to 101603000.0 in 2022, then fell by 14.14% to 115973000.0 in 2023, then rose by 9.82% to 104589000.0 in 2024, then skyrocketed by 58.96% to 42923000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for VIR at 42923000.0 in Q4 2025, 163141000.0 in Q3 2025, and 110958000.0 in Q2 2025.